2157 — Lepu Biopharma Share News
0.000.00%
Last trade - 00:00- HK$7.06bn
- HK$7.48bn
- CNY934.87m
Brief: Lepu Biopharma Says Orphan-Drug Designation Granted By FDA To MRG004A
Brief: Lepu Biopharma Says Fast Track Designation Granted By FDA To MRG003
Brief: Lepu Biopharma Says Co And/Or Its Units To Provide Lepu Medical With Cdmo Technical Services
Brief: Lepu Biopharma To Sell 15% Of Equity Interest Of Hangzhou Healsun Biopharma
Brief: Lepu Biopharma Posts FY Loss Attributable RMB689.1 Million
Brief: Keymed, Lepu Biopharma Jointly Announce Global Exclusive Licence Agreement With Astrazeneca For CMG901
HK-listed Lepu Biopharma jumps most in 3 months on licence deal with AstraZeneca
Brief: Lepu Biopharma Announces Inside Information On Exclusive License Deal With Astrazeneca For CMG901
Brief: Lepu Biopharma Co Says Conditional Marketing Approval Obtained In China For Puyouheng
Brief: Lepu Biopharma Co Says Conditional Marketing Approval Obtained In China For Puyouheng
Brief: Lepu Biopharma Says Loss For Year Attributable Up 73.8% To RMB1,011 Mln
China's Lepu Biopharma falls in Hong Kong debut